
This study investigated the impact of race on the treatment of idiopathic pulmonary fibrosis (IPF), a respiratory disease. Data from 47,184 IPF patients were analyzed, with the majority being White, followed by Hispanic, Black, and Asian patients. Pair-wise comparisons revealed that Black patients had significantly lower usage of antifibrotic treatment compared to White, Hispanic, and Asian patients. Mortality rates were lower for White patients on antifibrotic therapy, but this effect was not observed in Hispanic, Black, or Asian patients. The study highlights the need for urgent action to address racial disparities in treating IPF.
Like
Save
Share